Lekarze w leczeniu Rak wątroby stopnia 2 za granicą — Strona 3

Od ponad 28 lat specjalizuje się w chirurgii raka wątroby. Dr Ben-haim należy do czołowych izraelskich chirurgów onkologicznych układu pokarmowego w Centrum Medycznym Sourasky.

• Ekspert w zakresie operacji Whipple'a w złożonych przypadkach.
• Koncentruje się wyłącznie na nowotworach wątroby, trzustki i układu pokarmowego.
• Wykonuje zaawansowane zabiegi w schorzeniach onkologicznych.

Docent Tahsin Ozatli specjalizuje się w leczeniu raka piersi, płuc oraz układu pokarmowego. Przyjmuje pacjentów w Szpitalu Uniwersyteckim Istinye Liv.

• Specjalista chorób wewnętrznych z doświadczeniem w wielu szpitalach w Turcji
• Onkolog w Klinice Onkologii w Ankarze oraz w Regionalnym Szpitalu Szkoleniowo-Badawczym w Erzurum
• Studiował medycynę na Uniwersytecie Selcuk w Konya
• Uzyskał tytuł docenta w 2016 roku

Specjalizując się w wiroterapii — jednej z najnowszych dziedzin immunologii — dr Jaunalksne wnosi ponad 30-letnie doświadczenie w leczeniu raka wątroby.

• Kieruje Centrum Immunologii Klinicznej w Szpitalu Uniwersyteckim im. Paulsa Stradiņša
• Absolwentka Ryskiego Instytutu Medycznego, ukończyła staż podyplomowy w zakresie chorób wewnętrznych
• Koncentruje się na najnowocześniejszych metodach immunologicznych w leczeniu nowotworów

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr Auala Hubert kieruje Centrum Nowotworów Układu Pokarmowego w Centrum Medycznym Hadassah, wnosząc 33-letnie doświadczenie onkologiczne.

• Specjalizuje się w onkologii klinicznej i radioterapii
• Kieruje Centrum Nowotworów Układu Pokarmowego w Hadassah
• Posiada certyfikację specjalistyczną w dziedzinie onkologii i radioterapii
• Członkini Izraelskiego Towarzystwa Onkologii Klinicznej
• Biegle posługuje się językiem angielskim i hebrajskim w pracy z pacjentami zagranicznymi

Specjalizuje się w laparoskopowej chirurgii onkologicznej, kształcił się na Uniwersytecie Stambulskim. Dr Al koncentruje się na małoinwazyjnych technikach leczenia raka wątroby.

• Przeszedł szkolenie w zakresie zaawansowanej chirurgii laparoskopowej na Wydziale Medycznym Cerrahpaşa
• Wykonuje laparoskopowe operacje bariatryczne oraz zabiegi antyrefluksowe
• Ukończył Wydział Medyczny Uniwersytetu Ondokuz Mayıs
• Uzyskał specjalizację w szpitalu Farabi przy Wydziale Medycznym KTÜ

Docent dr Babek Tabandeh jest doświadczonym chirurgiem specjalizującym się w leczeniu raka wątroby oraz technikach małoinwazyjnych. Przeprowadza złożone operacje wątroby w szpitalu Medical Park Göztepe.

• Posiada ponad 25-letnie doświadczenie w chirurgii ogólnej i onkologicznej
• Koncentruje się na chirurgii małoinwazyjnej w celu zapewnienia lepszej rekonwalescencji
• Jest autorem ponad 40 prac naukowych
• Jest członkiem prestiżowego Amerykańskiego Kolegium Chirurgów (ACS)
• Należy również do Towarzystwa Transplantacji Wątroby

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr Ozden posiada ponad 20-letnie doświadczenie w dziedzinie onkologii, zdobyte na różnych stanowiskach klinicznych w całej Turcji.

• Specjalizuje się w onkologii klinicznej, ze szczególnym uwzględnieniem raka wątroby
• Kształcił się na renomowanym Wydziale Medycznym Cerrahpaşa Uniwersytetu Stambulskiego
• Posiada bogate doświadczenie w pracy zarówno w szpitalach prywatnych, jak i uniwersyteckich
• Stosuje spersonalizowane plany leczenia dla każdego pacjenta

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Doc. dr Nail Paksoy jest onkologiem klinicznym z certyfikatem ESMO w szpitalu Medipol Bahçelievler. Specjalizuje się w leczeniu raka wątroby i posiada bogate doświadczenie w badaniach klinicznych.

• Ukończył staż specjalizacyjny w Instytucie Onkologii Uniwersytetu Stambulskiego
• Pełnił funkcję współbadacza w 8 międzynarodowych onkologicznych badaniach klinicznych
• Opublikował liczne prace naukowe na temat skuteczności leczenia nowotworów
• Specjalizuje się w spersonalizowanym podejściu do terapii

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.